SEONGNAM, South Korea-- ( BUSINESS WIRE )--Qurient Co. Ltd. (KRX: 115180) has announced the commencement of a clinical trial ...

The myeloMATCH blood cancer trial is part of a larger effort by the NIH to find more personalized cancer treatments.

The National Institutes of Health (NIH) has launched a proof-of-concept precision medicine clinical trial to test new ...

Harvey Weinstein has been diagnosed with bone cancer, a source close to the incarcerated producer tells CNN. Weinstein’s ...

A leukemia diagnosis can feel like a sudden storm, upending lives and leaving patients and families grappling with ...

Four leading cancer research organizations in the United States and Canada announce the opening of patient enrollment to ...

The FDA granted orphan designation to Janssen Research & Development’s bleximenib as a treatment of acute myeloid leukemia, according ...

Adjusted survival outcomes were similar for patients with NPM1-mutated AML with intensive induction chemotherapy or ...

a clinical-stage biotechnology company developing therapeutics to address advanced cancer and cancer resistance, is pleased ...

Leukemia stem cells (LSCs) pose a significant challenge in treating acute myeloid leukemia (AML) due to their resistance to ...